Biotech
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 09/25/12 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that BREVAGen™ has been cleared for sale into the State of Florida ...
LEUVEN, BELGIUM: LEUVEN, BELGIUM -- (Marketwire) -- 09/25/12 -- TiGenix (EURONEXT BRUSSELS: TIG) announced today that after the successful cGMP inspection by the Dutch authorities earlier this year, it has now obtain ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 09/24/12 -- Molecular Insight Pharmaceuticals, Inc. today announced the initiation of a Phase 2 clinical trial of the Company's lead prostate cancer molecular im ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/24/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") reports that, subject to TSX Venture Exchange appr ...
MANCHESTER, NH: MANCHESTER, NH -- (Marketwire) -- 09/24/12 -- Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 09/24/12 -- MethylGene Inc. ("MethylGene" or the "Company") (TSX: MYG) announced today that Mr. Charles Grubsztajn has left the Company as Pre ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 09/24/12 -- Tonix Pharmaceuticals Holding Corp. (OTCQB: TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing non-addict ...
TUSTIN, CA: The Company Is Currently Conducting a Detailed Review, Including Assessing Its Impact on Overall Trial Results; Investors Should Not Rely on Previously Reported Clinical Data Disclosed From This Phase ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 09/24/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it has effected a 2-for-1 forward split of all shares of its common stock and increased the autho ...
WINSTON-SALEM, NC: Award Recognizes Dramatic Business Results Achieved in Novartis' First FDA-Approved eSource Study ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 09/21/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced fiscal 2013 first quarter financial results today for the three months ended Jul ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 09/21/12 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (Prima, the Company) announces that its CEO Matthew Lehman will present a corporate update at BIOX; Noble F ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 09/21/12 -- Immunovative, Inc. (OTCQB: IMUN) ("IMUN" or the "Company") announces today that it has appointed Mr. Bruce Harmon ("Mr. Harmon&quo ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 09/20/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has received consent from the TSX Venture Exchange (TSXV) to exten ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 09/20/12 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV), a clinical stage vaccine company, today announced th ...
PRINCETON, NJ: Chief Medical Officer to Discuss Company's Experiences in AG200-15 Phase III Trials ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 09/20/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today the pricing of an underwritten public offering of 21,425,000 units, with each unit consisting of one s ...
LONDON, ONTARIO: Effective in Cell Lines with Mutations in Cancer Suppressing Gene P53 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/20/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") is pleased to announce that a global, industry lea ...
NEW YORK, NY: CEO Discusses Company's Unique Approach to Treating Fibromyalgia by Improving Sleep Quality ...
